Short Interest in Check-Cap Ltd. (NASDAQ:CHEK) Declines By 11.4%

Check-Cap Ltd. (NASDAQ:CHEK) saw a significant drop in short interest in August. As of August 31st, there was short interest totalling 65,600 shares, a drop of 11.4% from the August 15th total of 74,000 shares. Based on an average trading volume of 10,700 shares, the short-interest ratio is presently 6.1 days. Currently, 1.5% of the company’s stock are sold short.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on shares of Check-Cap in a report on Saturday. They issued a “sell” rating on the stock.

Check-Cap Trading Down 1.1 %

CHEK stock traded down $0.02 on Wednesday, hitting $1.73. The company had a trading volume of 18,718 shares, compared to its average volume of 98,681. Check-Cap has a 12-month low of $1.64 and a 12-month high of $4.63. The stock’s 50-day simple moving average is $1.92 and its 200 day simple moving average is $2.11. The stock has a market cap of $10.12 million, a price-to-earnings ratio of -0.58 and a beta of 0.39.

About Check-Cap

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.